Thanks, I appreciate the feedback because that's whet I try to do - make this pretty technical stuff understandable to those who don't have the technical knowledge but have the illness and want to understand the research.
And thanks to all those who have left similar feedback (or just kind words).
Again thank you @Simon M for your clear presentation for forum members.
Could I ask where the funding for the remaining 3,000 samples collected will come from. Also the funding for the analysis. Do we have any sources identified or will this be what the proposed Business Manager will work on?
Could I ask where the funding for the remaining 3,000 samples collected will come from. Also the funding for the analysis. Do we have any sources identified or will this be what the proposed Business Manager will work on?
Jumping in to answer this. The search for further funding continues and, yes, is one of the responsibilities of the SequenceME and LC business manager, who has recently started.
Jumping in to answer this. The search for further funding continues and, yes, is one of the responsibilities of the SequenceME and LC business manager, who has recently started.
This site uses cookies to help personalise content, tailor your experience and to keep you logged in if you register.
By continuing to use this site, you are consenting to our use of cookies.